was read the article
array:24 [ "pii" => "S2387020616300687" "issn" => "23870206" "doi" => "10.1016/j.medcle.2016.04.043" "estado" => "S300" "fechaPublicacion" => "2016-01-01" "aid" => "3341" "copyright" => "Elsevier España, S.L.U.. All rights reserved" "copyrightAnyo" => "2015" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Med Clin. 2016;146:30-4" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2 "PDF" => 2 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0025775315003498" "issn" => "00257753" "doi" => "10.1016/j.medcli.2015.05.013" "estado" => "S300" "fechaPublicacion" => "2016-01-01" "aid" => "3341" "copyright" => "Elsevier España, S.L.U." "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Med Clin. 2016;146:30-4" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 32 "formatos" => array:2 [ "HTML" => 21 "PDF" => 11 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Artículo especial</span>" "titulo" => "Presión arterial ambulatoria, cronoterapia de la hipertensión y glaucoma" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "30" "paginaFinal" => "34" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Ambulatory blood pressure, chronotherapy of hypertension and glaucoma" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Ramón C. Hermida, Diana E. Ayala" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Ramón C." "apellidos" => "Hermida" ] 1 => array:2 [ "nombre" => "Diana E." "apellidos" => "Ayala" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2387020616300687" "doi" => "10.1016/j.medcle.2016.04.043" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020616300687?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775315003498?idApp=UINPBA00004N" "url" => "/00257753/0000014600000001/v1_201512260043/S0025775315003498/v1_201512260043/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2387020616300894" "issn" => "23870206" "doi" => "10.1016/j.medcle.2016.04.048" "estado" => "S300" "fechaPublicacion" => "2016-01-01" "aid" => "3369" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Med Clin. 2016;146:35-9" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Diagnosis and treatment</span>" "titulo" => "Migraine" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "35" "paginaFinal" => "39" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Migraña" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1759 "Ancho" => 1470 "Tamanyo" => 159802 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Options for the symptomatic treatment of migraine. NSAIDs: nonsteroidal anti-inflammatory drugs; IV: intravenous.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Nuria Riesco, Carmen García-Cabo, Julio Pascual" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Nuria" "apellidos" => "Riesco" ] 1 => array:2 [ "nombre" => "Carmen" "apellidos" => "García-Cabo" ] 2 => array:2 [ "nombre" => "Julio" "apellidos" => "Pascual" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0025775315004492" "doi" => "10.1016/j.medcli.2015.07.003" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775315004492?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020616300894?idApp=UINPBA00004N" "url" => "/23870206/0000014600000001/v3_201605230108/S2387020616300894/v3_201605230108/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2387020616300626" "issn" => "23870206" "doi" => "10.1016/j.medcle.2016.04.037" "estado" => "S300" "fechaPublicacion" => "2016-01-01" "aid" => "3306" "copyright" => "Elsevier España, S.L.U." "documento" => "article" "crossmark" => 1 "subdocumento" => "rev" "cita" => "Med Clin. 2016;146:24-9" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1 "PDF" => 1 ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review</span>" "titulo" => "Therapeutic holidays in osteoporosis: Long-term strategy of treatment with bisphosphonates" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "24" "paginaFinal" => "29" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Vacaciones terapéuticas en osteoporosis: estrategia en el tratamiento a largo plazo con bifosfonatos" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:9 [ "identificador" => "fig0010" "etiqueta" => "Fig. 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "fuente" => "Modified from Shane et al.<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">9</span></a>" "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1375 "Ancho" => 1625 "Tamanyo" => 141016 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Algorithm proposed by the <span class="elsevierStyleItalic">American Society for Bone and Mineral Research</span> for the therapeutic management of patients who have undergone bisphosphonate treatment for 5 years or more.</p> <p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">BP: bisphosphonate; FN: femoral neck; BMD: bone mineral density; Fx: fracture; BRM: bone remodelling markers.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "María Jesús Moro Álvarez, José Luis Neyro, Santos Castañeda" "autores" => array:3 [ 0 => array:2 [ "nombre" => "María Jesús" "apellidos" => "Moro Álvarez" ] 1 => array:2 [ "nombre" => "José Luis" "apellidos" => "Neyro" ] 2 => array:2 [ "nombre" => "Santos" "apellidos" => "Castañeda" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0025775315002560" "doi" => "10.1016/j.medcli.2015.03.017" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775315002560?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020616300626?idApp=UINPBA00004N" "url" => "/23870206/0000014600000001/v3_201605230108/S2387020616300626/v3_201605230108/en/main.assets" ] "en" => array:15 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Special article</span>" "titulo" => "Ambulatory blood pressure, chronotherapy of hypertension and glaucoma" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "30" "paginaFinal" => "34" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Ramón C. Hermida, Diana E. Ayala" "autores" => array:2 [ 0 => array:4 [ "nombre" => "Ramón C." "apellidos" => "Hermida" "email" => array:1 [ 0 => "rhermida@uvigo.es" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "Diana E." "apellidos" => "Ayala" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Laboratorio de Bioingeniería y Cronobiología, Atlantic Research Center for Information and Communication Technologies (AtlantTIC), Universidad de Vigo, Vigo, Pontevedra, Spain" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Presión arterial ambulatoria, cronoterapia de la hipertensión y glaucoma" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Although the diagnosis of hypertension is usually based on blood pressure (BP) values obtained conventionally in clinical practice, several independent studies have shown that the mean BP during sleep (mean at rest) is a better prognostic marker of cardiovascular risk (CV) than clinic BP and wakefulness mean or 24<span class="elsevierStyleHsp" style=""></span>h ambulatory BP.<a class="elsevierStyleCrossRefs" href="#bib0270"><span class="elsevierStyleSup">1–4</span></a> In general, these studies show that when the means of activity and rest are analyzed together, only the second is a significant and independent marker of CV morbidity and mortality in both hypertensive and normotensive patients.<a class="elsevierStyleCrossRef" href="#bib0290"><span class="elsevierStyleSup">5</span></a> However, most published results are derived from studies based in a single record of ambulatory monitoring (ABPM) of each participant at the time of inclusion, which has prevented the assessment of the possible modification of CV risk associated to a reduced average sleep BP. The results of the ambulatory monitoring study for prediction of cardiovascular events (MAPEC), the first and only one published so far in which participants were randomized depending on the time of administration of the antihypertensive medication (all medication in the morning when, after getting up or the full dose of one or more antihypertensive drugs at bedtime) and periodically evaluated during the 5.6 years of follow up by 48<span class="elsevierStyleHsp" style=""></span>h ABPM,<a class="elsevierStyleCrossRefs" href="#bib0275"><span class="elsevierStyleSup">2,6–9</span></a> not only corroborate that the average resting systolic BP (SBP) is a significant and independent predictor of CV events (unlike the average activity or clinic BP), but also gives evidence, for the first time, of a 17% decrease in CV risk for every 5<span class="elsevierStyleHsp" style=""></span>mmHg reduction in mean resting SBP during follow-up, regardless of changes in the clinic BP or average activity calculated from the ABPM.<a class="elsevierStyleCrossRefs" href="#bib0275"><span class="elsevierStyleSup">2,10–12</span></a> In addition, patients treated at bedtime had a <span class="elsevierStyleItalic">hazard ratio</span> of CV episodes significantly lower than those treated when getting up (0.39, 95% CI 0.29–0.51; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.001). These results, taken together, indicate that the average rest BP could be a new therapeutic target for cardiovascular risk reduction, which, obviously requires an accurate assessment of patients through ABPM<a class="elsevierStyleCrossRef" href="#bib0330"><span class="elsevierStyleSup">13</span></a> and that it can be achieved more effectively by the intake of the full dose of one or more antihypertensive drugs at bedtime.<a class="elsevierStyleCrossRefs" href="#bib0295"><span class="elsevierStyleSup">6–9</span></a> Although it has been documented that administration of antihypertensives at bedtime, compared with its intake when getting up significantly improves ambulatory BP control without increasing adverse effects,<a class="elsevierStyleCrossRef" href="#bib0335"><span class="elsevierStyleSup">14</span></a> treatment at bedtime may require some caution in hypertensive patients with glaucoma due to a possible, albeit controversial, relationship between BP during sleep and progression of visual field damage and ischaemic optic nerve damage in these patients.<a class="elsevierStyleCrossRefs" href="#bib0340"><span class="elsevierStyleSup">15,16</span></a></p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Circadian rhythm of ambulatory blood pressure and damage progression in patients with glaucoma</span><p id="par0010" class="elsevierStylePara elsevierViewall">The aetiology of primary open-angle glaucoma (OAG) remains uncertain, although it has been established that one of the causal mechanisms may be related to anomalies in ocular perfusion pressure (OPP).<a class="elsevierStyleCrossRef" href="#bib0350"><span class="elsevierStyleSup">17</span></a> The results of several studies suggest that a low OPP, usually measured as the difference between the BP and the intraocular pressure (IOP), may increase the risk of progression in the OAG.<a class="elsevierStyleCrossRef" href="#bib0355"><span class="elsevierStyleSup">18</span></a> By contrast, other authors have concluded that this association could be just an artefact due to the absence of the required correction for the value of the IOP,<a class="elsevierStyleCrossRef" href="#bib0360"><span class="elsevierStyleSup">19</span></a> delving, that way, into an already open dispute. The possible relationship between the OAG and the BP is even less evident.<a class="elsevierStyleCrossRef" href="#bib0365"><span class="elsevierStyleSup">20</span></a> Several epidemiological studies, limited by the use of different criteria for defining hypertension and by the excessively reduced number of evaluated subjects who developed OAG, concluded that hypertension is a possible risk factor for the development and progression of OAG.<a class="elsevierStyleCrossRef" href="#bib0365"><span class="elsevierStyleSup">20</span></a> However, more recent studies failed to document any correlation, or even an inverse relationship between hypertension and OAG.<a class="elsevierStyleCrossRef" href="#bib0370"><span class="elsevierStyleSup">21</span></a> Circadian variation of high amplitude characteristic of IOP<a class="elsevierStyleCrossRef" href="#bib0375"><span class="elsevierStyleSup">22</span></a> is an additional aspect that has scarcely been taken into account in the diagnosis, treatment and progression of glaucoma.</p><p id="par0015" class="elsevierStylePara elsevierViewall">The relationship between the circadian pattern of the BP and glaucoma is not without controversy. The results of several cross-sectional and prospective studies on the possible relationship of circadian variations in BP with damage to the visual field and progression of glaucoma patients suggest that variations in nocturnal BP could be a potential risk factor, but the results are far from conclusive.<a class="elsevierStyleCrossRef" href="#bib0380"><span class="elsevierStyleSup">23</span></a> Among other authors, Krasinska et al.,<a class="elsevierStyleCrossRef" href="#bib0385"><span class="elsevierStyleSup">24</span></a> conducted a cross sectional study in 69 hypertensive patients with OAG evaluated with 24<span class="elsevierStyleHsp" style=""></span>h ABPM and, therefore, of poor reproducibility,<a class="elsevierStyleCrossRef" href="#bib0390"><span class="elsevierStyleSup">25</span></a> classified according to the dip (decline percentage in BP during sleep compared to the mean BP during the activity period) of the mean BP (MBP), concluding that patients with a <span class="elsevierStyleItalic">non-dipper</span> profile (dip<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>10%) had greater visual field defect and degeneration of the optic nerve fibres than <span class="elsevierStyleItalic">dipper</span> patients (dip<span class="elsevierStyleHsp" style=""></span>≥<span class="elsevierStyleHsp" style=""></span>10%). Apart from its transversal nature, this study has important methodological limitations, including: (i) improper use of patients for classification based on MBP dip of the same 10% threshold commonly used for PAS, as the circadian variation range of both pressures is significantly different; (ii) the use of a fixed schedule to calculate the mean of activity and rest in ABPM for all patients regardless of their individual cycle of activity and rest, and (iii) the absence of correction of results by IOP values. Meanwhile, Tokunaga et al.,<a class="elsevierStyleCrossRef" href="#bib0395"><span class="elsevierStyleSup">26</span></a> prospectively evaluated the relationship between the dip of ambulatory BP and progression of visual field defects in 15 patients with OAG and 23 with normotensive glaucoma (NTG), with 4-year follow-up after being evaluated with 48<span class="elsevierStyleHsp" style=""></span>h ABPM at the time of their selection. The progression of damage was higher in <span class="elsevierStyleItalic">non-dipper</span> (7 of 14 patients) and extreme <span class="elsevierStyleItalic">dipper</span> patients (dip<span class="elsevierStyleHsp" style=""></span>≥<span class="elsevierStyleHsp" style=""></span>20%; 2 out of 4 patients) compared to those with a physiologically normal <span class="elsevierStyleItalic">dipper</span> profile (4 out of 20 patients). Among the 34 participants with dip<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>20% (<span class="elsevierStyleItalic">non-dipper</span> and <span class="elsevierStyleItalic">dipper</span>), those who showed progression to visual field defects had significantly lower dip than patients without progression (5.6<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>7.5% versus 11.2<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>5.2%; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.002), thus showing an association between the absence of adequate reduction in BP during sleep and progression of damage in patients with glaucoma. The results of the Collignon et al. study,<a class="elsevierStyleCrossRef" href="#bib0400"><span class="elsevierStyleSup">27</span></a> conducted in 51 patients with OAG and 19 with NTG, with a 2-year follow-up period after being evaluated by 24<span class="elsevierStyleHsp" style=""></span>h ABPM, were similar, despite the fact that their division in <span class="elsevierStyleItalic">non-dipper</span>, <span class="elsevierStyleItalic">dipper</span> and extreme <span class="elsevierStyleItalic">dipper</span> categories was established based on dip thresholds of 5 and 10%, rather than 10 and 20% thresholds, common throughout medical literature. Although the sample size of these prospective studies is extremely small, the results show that the BP circadian pattern, as a whole, specifically <span class="elsevierStyleItalic">non-dipper</span> and extreme <span class="elsevierStyleItalic">dipper</span> profiles, could contribute to the progression of damage in glaucoma patients, and not only the nocturnal BP level.</p><p id="par0020" class="elsevierStylePara elsevierViewall">However, several authors have proposed the existence of a possible relationship between the level of BP during sleep and glaucoma. Specifically, it has been speculated that nocturnal hypotension may be a damage progression factor in patients with glaucoma.<a class="elsevierStyleCrossRef" href="#bib0365"><span class="elsevierStyleSup">20</span></a> Charlson et al.,<a class="elsevierStyleCrossRef" href="#bib0405"><span class="elsevierStyleSup">28</span></a> evaluated during 1-year follow-up 85 patients with TNG and previous history of progression of visual field loss, with 48<span class="elsevierStyleHsp" style=""></span>h ambulatory blood pressure monitoring every 6 months. The amount of time in which the MBP during sleep was <10% of the MBP's activity average was a significant predictor (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.02) of damage progression, although not very specific. Apart from the small sample size and other methodological issues which limited the conclusions of the study (absence of information on the degree of association of multiple parameters evaluated with damage progression, lack of statistical significance correction due to the high number of tests performed; damage progression analyzed exclusively in binary form, i.e., as presence/absence, etc.), the definition of “hypotension” based on a predetermined decrease of MBP level (10<span class="elsevierStyleHsp" style=""></span>mmHg) during sleep in relation to the MBP during activity is, at least, debatable.</p><p id="par0025" class="elsevierStylePara elsevierViewall">In this regard, it is noteworthy that international guidelines for the diagnosis and treatment of hypertension systematically have omitted, probably intentionally, any definition of “nocturnal hypotension”.<a class="elsevierStyleCrossRef" href="#bib0410"><span class="elsevierStyleSup">29</span></a> Several authors, however, have used specific thresholds of the MBP to establish the presence of nocturnal hypotension episodes. Thus, a MBP<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>50<span class="elsevierStyleHsp" style=""></span>mmHg could be considered low as it corresponds with the lower threshold of cerebral autoregulation in healthy people. Moreover, MBP<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>70<span class="elsevierStyleHsp" style=""></span>mmHg represents the threshold of cerebral autoregulation in hypertensive patients.<a class="elsevierStyleCrossRefs" href="#bib0415"><span class="elsevierStyleSup">30,31</span></a> Such autoregulation is the intrinsic capacity of the vessels in target organs (heart, brain, kidney) to dilate and constrict in response to changes in perfusion pressure, thereby maintaining a relatively constant blood flow.</p><p id="par0030" class="elsevierStylePara elsevierViewall">The use of a constant BP threshold to define hypertension/hypotension ignores the predictable variation of BP during 24<span class="elsevierStyleHsp" style=""></span>h resulting from the interrelation of various physiological, neuroendocrine and environmental factors: (i) changes in behaviour associated with the pattern of activity-rest; (ii) divergence in relation to light-dark cycle in ambient temperature, humidity and noise; and (iii) endogen circadian variation (∼24<span class="elsevierStyleHsp" style=""></span>h) in neuroendocrine, endothelial, vasoactive and haemodynamic parameters including noradrenaline and plasma adrenaline (autonomic nervous system), atrial natriuretic peptide and calcitonin, and the <span class="elsevierStyleItalic">renin–angiotensin–aldosterone system</span> (RAAS).<a class="elsevierStyleCrossRefs" href="#bib0425"><span class="elsevierStyleSup">32,33</span></a> Thus, it is proposed that the reference thresholds for the diagnosis of hypertension/hypotension should be established taking into account the documented factors that significantly affect BP regulation and CV risk.<a class="elsevierStyleCrossRef" href="#bib0330"><span class="elsevierStyleSup">13</span></a> An appropriate reference limit could be a tolerance range that includes a specific percentage of the reference population (normotensive) with a certain confidence level.<a class="elsevierStyleCrossRefs" href="#bib0435"><span class="elsevierStyleSup">34,35</span></a> Once the BP reference threshold has been set, given by the upper limit of the tolerance range, the so-called hyperbaric index as a measure of the load exerted by the blood on the arterial wall, it can be calculated as the total area of excess BP above the dynamic reference upper limit during 24<span class="elsevierStyleHsp" style=""></span>h.<a class="elsevierStyleCrossRefs" href="#bib0445"><span class="elsevierStyleSup">36–38</span></a> The hyperbaric index, as well as the duration of the excess (percentage of 24<span class="elsevierStyleHsp" style=""></span>h where the subject's BP exceeds the upper limit of the tolerance range), might be used for the diagnosis of hypertension with high reproducibility, sensitivity and specificity.<a class="elsevierStyleCrossRef" href="#bib0450"><span class="elsevierStyleSup">37</span></a> Equivalently, the hypobaric index, defined as the total area of BP deficit below the lower tolerance limit, both during 24<span class="elsevierStyleHsp" style=""></span>h and for specific periods of activity and rest, can be used as a sensitive parameter to evaluate hypotension, especially in patients on antihypertensive therapy.<a class="elsevierStyleCrossRefs" href="#bib0330"><span class="elsevierStyleSup">13,37,38</span></a> Using the proposed criterion of a hypobaric index<span class="elsevierStyleHsp" style=""></span>≥<span class="elsevierStyleHsp" style=""></span>50<span class="elsevierStyleHsp" style=""></span>mmHg/h,<a class="elsevierStyleCrossRef" href="#bib0330"><span class="elsevierStyleSup">13</span></a> the prevalence of hypertension during sleep in the last valuation with 48<span class="elsevierStyleHsp" style=""></span>h ABPM of MAPEC's study participants,<a class="elsevierStyleCrossRef" href="#bib0295"><span class="elsevierStyleSup">6</span></a> randomized to ingest all the antihypertensive medication after getting up in the morning or the full dose of a drug or more at bedtime was 0.3% and 0.4%, respectively (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.640 between groups). Even using the more stringent criterion of a hypobaric index<span class="elsevierStyleHsp" style=""></span>≥<span class="elsevierStyleHsp" style=""></span>10<span class="elsevierStyleHsp" style=""></span>mmHg/h, the prevalence of nocturnal hypotension was very low regardless of whether the treatment is ingested when getting up or at bedtime (2.0 and 2.3%, respectively; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.545).</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Chronotherapy of hypertension and glaucoma</span><p id="par0035" class="elsevierStylePara elsevierViewall">Apart from the clear dispute between the possible relationship with glaucoma hypertension, nocturnal hypotension and/or different patterns of circadian variation in BP, there is no evidence that increased BP, especially during sleep, reduces damage progression in glaucoma.<a class="elsevierStyleCrossRef" href="#bib0350"><span class="elsevierStyleSup">17</span></a> In what seems to be the only report so far of antihypertensive chronotherapy in patients with glaucoma, Krasinska et al.,<a class="elsevierStyleCrossRef" href="#bib0460"><span class="elsevierStyleSup">39</span></a> studied the effects of the time of intake of antihypertensive medication in 88 patients with OAG, all hypertensives under treatment and supposedly controlled. Patients were divided into two treatment groups according to the results of the baseline 24<span class="elsevierStyleHsp" style=""></span>h ABPM: (i) intake of the whole antihypertensive medication in the morning (at pre-set times between 0800 and 0900) on the basis that patients had a <span class="elsevierStyleItalic">dipper</span> profile (n<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>43); (ii) intake of one drug at night (always between 20.00 and 21.00 regardless of the activity/rest cycle of each patient) and the remaining medication in the morning, either because of having a <span class="elsevierStyleItalic">non-dipper</span> profile (n<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>23) or because of having an “excessive” BP increase in the morning (value not specified; n<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>10) or because the authors had the “conviction” that the effect of the treatment received by the patients lasted <24<span class="elsevierStyleHsp" style=""></span>h (unspecified treatment; n<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>12). The drug administered at night in the second group was only an angiotensin converting enzyme inhibitor (ramipril, 33 cases; perindopril, 3 cases) or amlodipine (9 cases). At 6 months of this nonrandomized division, patients treated with a drug at night and the rest in the morning, compared to those treated with all medication in the morning, showed lower OPP overnight, further loss of visual fields and smaller amplitude of evoked potentials.</p><p id="par0040" class="elsevierStylePara elsevierViewall">The conclusions of Krasinska et al.,<a class="elsevierStyleCrossRef" href="#bib0460"><span class="elsevierStyleSup">39</span></a> however, should be taken with extreme caution and require proper validation due to its many and obvious limitations, including: (i) participants were not randomized to 2 treatment groups, but were classified based on pre-set and, at least, arguable criteria; (ii) the manuscript does not provide any details about which were the baseline characteristics of patients and their required similarity between treatment groups, including IOP, OPP, damage of visual fields, amplitude of evoked potentials, ischaemic damage to the optic nerve, or progression time for glaucoma; (iii) the results only provide information of the variables at the end of the study and not about their change during the 6 months of treatment, which, together with the absence of randomization, invalidates all findings; (iv) the classification criteria for administering a drug at night are not only arbitrary but contradictory; thus, a greater increase in morning BP is associated with a higher dip towards a <span class="elsevierStyleItalic">dipper</span> profile and therefore, with lower, not higher, CV risk<a class="elsevierStyleCrossRef" href="#bib0275"><span class="elsevierStyleSup">2</span></a>; therefore, both from the standpoint of the BP circadian pattern as well as the CV risk, patients with an elevated morning increase in BP are closer to <span class="elsevierStyleItalic">dipper</span> subjects rather than <span class="elsevierStyleItalic">non-dipper</span>, with whom, however, they were included in the same treatment group (a drug at bedtime); (v) the choice of drugs and doses to be administered at night is not justified nor does it respond to objective clinical or therapeutic criteria, as dihydropyridines are characterized by not modifying the ABP dip<a class="elsevierStyleCrossRefs" href="#bib0465"><span class="elsevierStyleSup">40,41</span></a>; (vi) as in other works by the same authors<a class="elsevierStyleCrossRef" href="#bib0385"><span class="elsevierStyleSup">24</span></a> the use of a fixed schedule to calculate the mean waking and sleep BP for all patients, regardless of their individual cycle of activity and rest, is inappropriate, which, together with poor reproducibility of 24<span class="elsevierStyleHsp" style=""></span>h<a class="elsevierStyleCrossRef" href="#bib0390"><span class="elsevierStyleSup">25</span></a> ABPM leads to great uncertainty when it comes to a proper classification of patients regarding <span class="elsevierStyleItalic">dipper</span> or <span class="elsevierStyleItalic">non-dipper</span><a class="elsevierStyleCrossRef" href="#bib0330"><span class="elsevierStyleSup">13</span></a> and (vii) the use of clinical or home BP to establish that all participants were “hypertension controlled” regardless of the results of the ABPM is inadequate<a class="elsevierStyleCrossRef" href="#bib0330"><span class="elsevierStyleSup">13</span></a>; when ABPM is available, clinical BP is irrelevant to assess the degree of control, given the high CV risk of masked hypertension and, more specifically, of nocturnal hypertension.<a class="elsevierStyleCrossRef" href="#bib0330"><span class="elsevierStyleSup">13</span></a> For those reasons, unfortunately, the study of Krasinska et al.,<a class="elsevierStyleCrossRef" href="#bib0460"><span class="elsevierStyleSup">39</span></a> does not provide evidence for or against treatment at bedtime in hypertensive patients with glaucoma.</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Discussion</span><p id="par0045" class="elsevierStylePara elsevierViewall">The morbidity and mortality associated with hypertension and glaucoma is obviously different. Glaucoma, with a prevalence of around 2% of the population over 40 years is, after cataracts and followed by diabetic retinopathy, the leading risk factor for visual impairment and blindness. Hypertension, meanwhile, is a chronic process with a prevalence over 40% of the Western adult population. In our area, more than 45% of total mortality is related to hypertension, mainly through stroke, coronary heart disease and heart failure. Current knowledge of several clinically relevant aspects of diagnosis and treatment of hypertension indicates that<a class="elsevierStyleCrossRef" href="#bib0475"><span class="elsevierStyleSup">42</span></a>: (i) between the various parameters that can be calculated from the measurement of clinic, home and ambulatory BP, <span class="elsevierStyleItalic">only</span> the mean ambulatory BP during sleep is a significant and independent marker of CV morbidity and mortality<a class="elsevierStyleCrossRefs" href="#bib0275"><span class="elsevierStyleSup">2,4</span></a>; (ii) reducing cardiovascular risk in hypertensive patients is associated significantly and independently <span class="elsevierStyleItalic">only</span> with the progressive decrease due to the treatment of mean ambulatory BP during sleep and not to changes in mean clinical activity or BP<a class="elsevierStyleCrossRefs" href="#bib0275"><span class="elsevierStyleSup">2,10–12</span></a>; and (iii) the intake of antihypertensive drugs in one dose at bedtime, rather than on getting up, especially those that modulate or block the RAAS,<a class="elsevierStyleCrossRefs" href="#bib0480"><span class="elsevierStyleSup">43,44</span></a> improves control of ambulatory BP during sleep<a class="elsevierStyleCrossRefs" href="#bib0465"><span class="elsevierStyleSup">40,41,43,44</span></a> and significantly increases survival without CV events.<a class="elsevierStyleCrossRefs" href="#bib0295"><span class="elsevierStyleSup">6,45,46</span></a> In the MAPEC study,<a class="elsevierStyleCrossRef" href="#bib0295"><span class="elsevierStyleSup">6</span></a> intake of at least one antihypertensive drug at full dose at bedtime, compared with intake of all medications when getting up, reduced the risk of total events after 5.6 years of follow-up by 61%, and major events (CV death, heart attack and stroke) by 67%, which was significantly associated with better BP control during sleep. Moreover, with treatment at bedtime the risk of retinal artery occlusion was reduced by 79%<a class="elsevierStyleCrossRef" href="#bib0295"><span class="elsevierStyleSup">6</span></a> and diabetic retinopathy by 92%.<a class="elsevierStyleCrossRef" href="#bib0300"><span class="elsevierStyleSup">7</span></a> Pending a possible confirmation by other ongoing prospective studies,<a class="elsevierStyleCrossRefs" href="#bib0500"><span class="elsevierStyleSup">47–49</span></a> besides those recently published,<a class="elsevierStyleCrossRefs" href="#bib0490"><span class="elsevierStyleSup">45,46</span></a> these results document the benefits of proper use of ABPM in assessing cardiovascular risk and chronotherapy (timing of treatment with the aim of improving the efficiency and/or reduce adverse effects) in reducing the said risk.</p><p id="par0050" class="elsevierStylePara elsevierViewall">In patients with glaucoma, beyond the controversies summarized in this document and the uncertainty derived from them, the possible influence of BP during sleep on the progression of damage makes ABPM use advisable as a clinical assessment tool. If the patient with glaucoma is also hypertensive, regular use of the ABPM should be essential, both for assessing the degree of ABP control as well as to objectively determine the absence of nocturnal hypotension, especially if, based on the current recommendations of a growing number of international scientific societies,<a class="elsevierStyleCrossRefs" href="#bib0330"><span class="elsevierStyleSup">13,50–53</span></a> the option of bedtime administration of antihypertensives is chosen as a more favourable regimen for reducing CV risk.</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Conflict of interests</span><p id="par0055" class="elsevierStylePara elsevierViewall">The authors report no conflicts of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:6 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 1 => array:2 [ "identificador" => "sec0010" "titulo" => "Circadian rhythm of ambulatory blood pressure and damage progression in patients with glaucoma" ] 2 => array:2 [ "identificador" => "sec0015" "titulo" => "Chronotherapy of hypertension and glaucoma" ] 3 => array:2 [ "identificador" => "sec0020" "titulo" => "Discussion" ] 4 => array:2 [ "identificador" => "sec0025" "titulo" => "Conflict of interests" ] 5 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2015-04-22" "fechaAceptado" => "2015-05-28" "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Hermida RC, Ayala DE. Presión arterial ambulatoria, cronoterapia de la hipertensión y glaucoma. Med Clin (Barc). 2016;146:30–34.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:53 [ 0 => array:3 [ "identificador" => "bib0270" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R.H. Fagard" 1 => "H. Celis" 2 => "L. Thijs" 3 => "J.A. Staessen" 4 => "D.L. Clement" 5 => "M.L. De Buyzere" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/HYPERTENSIONAHA.107.100727" "Revista" => array:6 [ "tituloSerie" => "Hypertension" "fecha" => "2008" "volumen" => "51" "paginaInicial" => "55" "paginaFinal" => "61" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18039980" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0275" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "R.C. Hermida" 1 => "D.E. Ayala" 2 => "A. Mojón" 3 => "J.R. Fernández" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jacc.2011.04.043" "Revista" => array:6 [ "tituloSerie" => "J Am Coll Cardiol" "fecha" => "2011" "volumen" => "58" "paginaInicial" => "1165" "paginaFinal" => "1173" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21884956" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0280" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R. Minutolo" 1 => "R. Agarwal" 2 => "S. Borrelli" 3 => "P. Chiodini" 4 => "V. Bellizzi" 5 => "F. Nappi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/archinternmed.2011.230" "Revista" => array:6 [ "tituloSerie" => "Arch Intern Med" "fecha" => "2011" "volumen" => "171" "paginaInicial" => "1090" "paginaFinal" => "1098" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21709109" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0285" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prognostic impact from clinic, daytime, and nighttime systolic blood pressure in 9 cohorts on 13,844 patients with hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "G.C. Roush" 1 => "R.H. Fagard" 2 => "G.F. Salles" 3 => "S.D. Pierdomenico" 4 => "G. Reboldi" 5 => "P. Verdecchia" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/HJH.0000000000000355" "Revista" => array:6 [ "tituloSerie" => "J Hypertens" "fecha" => "2014" "volumen" => "32" "paginaInicial" => "2332" "paginaFinal" => "2340" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25333682" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0290" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level – the “normotensive non-dipper” paradox" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "R.C. Hermida" 1 => "D.E. Ayala" 2 => "A. Mojón" 3 => "J.R. Fernández" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3109/07420528.2012.701127" "Revista" => array:6 [ "tituloSerie" => "Chronobiol Int" "fecha" => "2013" "volumen" => "30" "paginaInicial" => "87" "paginaFinal" => "98" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23039824" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0295" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "R.C. Hermida" 1 => "D.E. Ayala" 2 => "A. Mojón" 3 => "J.R. Fernández" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3109/07420528.2010.510230" "Revista" => array:6 [ "tituloSerie" => "Chronobiol Int" "fecha" => "2010" "volumen" => "27" "paginaInicial" => "1629" "paginaFinal" => "1651" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20854139" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0300" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Influence of time of day of blood pressure-lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "R.C. Hermida" 1 => "D.E. Ayala" 2 => "A. Mojón" 3 => "J.R. Fernández" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2337/dc11-0297" "Revista" => array:6 [ "tituloSerie" => "Diabetes Care" "fecha" => "2011" "volumen" => "34" "paginaInicial" => "1270" "paginaFinal" => "1276" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21617110" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0305" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "R.C. Hermida" 1 => "D.E. Ayala" 2 => "A. Mojón" 3 => "J.R. Fernández" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1681/ASN.2011040361" "Revista" => array:6 [ "tituloSerie" => "J Am Soc Nephrol" "fecha" => "2011" "volumen" => "22" "paginaInicial" => "2313" "paginaFinal" => "2321" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22025630" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0310" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cardiovascular risk of resistant hypertension: dependence on treatment-time regimen of blood pressure-lowering medications" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "D.E. Ayala" 1 => "R.C. Hermida" 2 => "A. Mojón" 3 => "J.R. Fernández" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3109/07420528.2012.701455" "Revista" => array:6 [ "tituloSerie" => "Chronobiol Int" "fecha" => "2013" "volumen" => "30" "paginaInicial" => "340" "paginaFinal" => "352" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23077973" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0315" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Sleep-time blood pressure as a therapeutic target for cardiovascular risk reduction in type 2 diabetes" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "R.C. Hermida" 1 => "D.E. Ayala" 2 => "A. Mojón" 3 => "J.R. Fernández" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/ajh.2011.231" "Revista" => array:6 [ "tituloSerie" => "Am J Hypertens" "fecha" => "2012" "volumen" => "25" "paginaInicial" => "325" "paginaFinal" => "334" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22158066" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0320" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "R.C. Hermida" 1 => "D.E. Ayala" 2 => "J.R. Fernández" 3 => "A. Mojón" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3109/07420528.2012.702581" "Revista" => array:6 [ "tituloSerie" => "Chronobiol Int" "fecha" => "2013" "volumen" => "30" "paginaInicial" => "68" "paginaFinal" => "86" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23181592" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0325" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Sleep-time ambulatory blood pressure as a novel therapeutic target for cardiovascular risk reduction" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "R.C. Hermida" 1 => "D.E. Ayala" 2 => "A. Mojón" 3 => "M.H. Smolensky" 4 => "F. Portaluppi" 5 => "J.R. Fernández" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/jhh.2014.1" "Revista" => array:6 [ "tituloSerie" => "J Hum Hypertens" "fecha" => "2014" "volumen" => "28" "paginaInicial" => "567" "paginaFinal" => "574" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24500721" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0330" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals. Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R.C. Hermida" 1 => "M.H. Smolensky" 2 => "D.E. Ayala" 3 => "F. Portaluppi" 4 => "J.J. Crespo" 5 => "F. Fabbian" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3109/07420528.2013.750490" "Revista" => array:6 [ "tituloSerie" => "Chronobiol Int" "fecha" => "2013" "volumen" => "30" "paginaInicial" => "355" "paginaFinal" => "410" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23517220" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0335" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evening versus morning dosing regimen drug therapy for hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "P. Zhao" 1 => "P. Xu" 2 => "C. Wan" 3 => "Z. Wang" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/14651858.CD004184.pub2" "Revista" => array:5 [ "tituloSerie" => "Cochrane Database Syst Rev" "fecha" => "2011" "volumen" => "10" "paginaInicial" => "CD004184" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21975743" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0340" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cronoterapia con antihipertensivos y glaucoma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "F.J. Fernández" 1 => "D. Merino" 2 => "P. Sesma" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.medcli.2015.03.018" "Revista" => array:2 [ "tituloSerie" => "Med Clin (Barc)" "fecha" => "2015" ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0345" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cronoterapia de la hipertensión arterial y glaucoma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "R.C. Hermida" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.medcli.2015.05.013" "Revista" => array:2 [ "tituloSerie" => "Med Clin (Barc)" "fecha" => "2015" ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0350" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Blood pressure, perfusion pressure, and glaucoma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J. Caprioli" 1 => "A.L. Coleman" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ajo.2010.01.018" "Revista" => array:6 [ "tituloSerie" => "Am J Ophthalmol" "fecha" => "2010" "volumen" => "149" "paginaInicial" => "704" "paginaFinal" => "712" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20399924" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0355" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Ocular perfusion pressure and glaucoma: clinical trial and epidemiologic findings" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "M.C. Leske" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/ICU.0b013e32831eef82" "Revista" => array:6 [ "tituloSerie" => "Curr Opin Ophthalmol" "fecha" => "2009" "volumen" => "20" "paginaInicial" => "73" "paginaFinal" => "78" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19240538" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0360" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Ocular perfusion pressure and the incidence of glaucoma: real effect or artifact? The Rotterdam Study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "W.D. Ramdas" 1 => "R.C. Wolfs" 2 => "A. Hofman" 3 => "P.T. de Jong" 4 => "J.R. Vingerling" 5 => "N.M. Jansonius" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1167/iovs.11-7376" "Revista" => array:6 [ "tituloSerie" => "Invest Ophthalmol Vis Sci" "fecha" => "2011" "volumen" => "52" "paginaInicial" => "6875" "paginaFinal" => "6881" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21715354" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0365" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Relationships among systemic blood pressure, intraocular pressure, and open-angle glaucoma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "S. Deokule" 1 => "R.N. Weinreb" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3129/i08-061" "Revista" => array:6 [ "tituloSerie" => "Can J Ophthalmol" "fecha" => "2008" "volumen" => "43" "paginaInicial" => "302" "paginaFinal" => "307" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18493272" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0370" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk factors for incident open-angle glaucoma: the Barbados Eye Studies" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "BESs Study Group" "etal" => false "autores" => array:5 [ 0 => "M.C. Leske" 1 => "S.Y. Wu" 2 => "A. Hennis" 3 => "R. Honkanen" 4 => "B. Nemesure" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ophtha.2007.03.017" "Revista" => array:6 [ "tituloSerie" => "Ophthalmology" "fecha" => "2008" "volumen" => "115" "paginaInicial" => "85" "paginaFinal" => "93" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17629563" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0375" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Twenty-four-hour pattern of intraocular pressure in untreated patients with ocular hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "T.M. Grippo" 1 => "J.H.K. Liu" 2 => "N. Zebardast" 3 => "T.B. Arnold" 4 => "G.H. Moore" 5 => "R.N. Weinreb" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1167/iovs.12-10709" "Revista" => array:6 [ "tituloSerie" => "Invest Ophthalmol Vis Sci" "fecha" => "2013" "volumen" => "54" "paginaInicial" => "512" "paginaFinal" => "517" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23211815" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0380" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The circadian variations in systemic blood pressure, ocular perfusion pressure, and ocular blood flow: risk factors for glaucoma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "A. Werne" 1 => "A. Harris" 2 => "D. Moore" 3 => "I. BenZion" 4 => "B. Siesky" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.survophthal.2008.08.021" "Revista" => array:6 [ "tituloSerie" => "Surv Ophthalmol" "fecha" => "2008" "volumen" => "53" "paginaInicial" => "559" "paginaFinal" => "567" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19026319" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0385" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A marked fall in nocturnal blood pressure is associated with the stage of primary open-angle glaucoma in patients with arterial hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "B. Krasinska" 1 => "M. Karolczak-Kulesza" 2 => "Z. Krasinski" 3 => "K. Pawlaczyk-Gabriel" 4 => "A. Niklas" 5 => "J. Gluszek" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3109/08037051.2010.538964" "Revista" => array:6 [ "tituloSerie" => "Blood Press" "fecha" => "2011" "volumen" => "20" "paginaInicial" => "171" "paginaFinal" => "181" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21133823" "web" => "Medline" ] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0390" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Ambulatory blood pressure monitoring: importance of sampling rate and duration – 48 versus 24<span class="elsevierStyleHsp" style=""></span>hours – on the accurate assessment of cardiovascular risk" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "R.C. Hermida" 1 => "D.E. Ayala" 2 => "M.J. Fontao" 3 => "A. Mojón" 4 => "J.R. Fernández" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3109/07420528.2012.701457" "Revista" => array:6 [ "tituloSerie" => "Chronobiol Int" "fecha" => "2013" "volumen" => "30" "paginaInicial" => "55" "paginaFinal" => "67" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23077972" "web" => "Medline" ] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0395" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Association between nocturnal blood pressure reduction and progression of visual field defect in patients with primary open-angle glaucoma or normal-tension glaucoma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "T. Tokunaga" 1 => "K. Kashiwagi" 2 => "T. Tsumura" 3 => "K. Taguchi" 4 => "S. Tsukahara" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s10384-003-0071-6" "Revista" => array:6 [ "tituloSerie" => "Jpn J Ophthalmol" "fecha" => "2004" "volumen" => "48" "paginaInicial" => "380" "paginaFinal" => "385" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15295667" "web" => "Medline" ] ] ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0400" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Ambulatory blood pressure monitoring in glaucoma patients. The nocturnal systolic dip and its relationship with disease progression" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "N. Collignon" 1 => "W. Dewe" 2 => "S. Guillaume" 3 => "J. Collignon-Brach" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Int Ophthalmol" "fecha" => "1998" "volumen" => "22" "paginaInicial" => "19" "paginaFinal" => "25" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10090444" "web" => "Medline" ] ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0405" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Nocturnal systemic hypotension increases the risk of glaucoma progression" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M.E. Charlson" 1 => "C.G. de Moraes" 2 => "A. Link" 3 => "M.T. Wells" 4 => "G. Harmon" 5 => "J.C. Peterson" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ophtha.2014.04.016" "Revista" => array:6 [ "tituloSerie" => "Ophthalmology" "fecha" => "2014" "volumen" => "121" "paginaInicial" => "2004" "paginaFinal" => "2012" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24869467" "web" => "Medline" ] ] ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0410" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "G. Mancia" 1 => "R. Fagard" 2 => "K. Narkiewicz" 3 => "J. Redón" 4 => "A. Zanchetti" 5 => "M. Böhm" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/01.hjh.0000431740.32696.cc" "Revista" => array:6 [ "tituloSerie" => "J Hypertens" "fecha" => "2013" "volumen" => "31" "paginaInicial" => "1281" "paginaFinal" => "1357" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23817082" "web" => "Medline" ] ] ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0415" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cerebral autoregulation and blood pressure lowering" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "S. Ruland" 1 => "V. Aiyagari" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/HYPERTENSIONAHA.107.087502" "Revista" => array:6 [ "tituloSerie" => "Hypertension" "fecha" => "2007" "volumen" => "49" "paginaInicial" => "977" "paginaFinal" => "978" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17353508" "web" => "Medline" ] ] ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0420" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Disturbed cerebral autoregulation" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "L. Edvinsson" 1 => "E. MacKenzie" 2 => "J. McCulloch" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:4 [ "titulo" => "Cerebral blood flow and metabolism" "paginaInicial" => "599" "paginaFinal" => "606" "serieFecha" => "1993" ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib0425" "etiqueta" => "32" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Circadian rhythms and cardiovascular health" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "F. Portaluppi" 1 => "R. Tiseo" 2 => "M.H. Smolensky" 3 => "R.C. Hermida" 4 => "D.E. Ayala" 5 => "F. Fabbian" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.smrv.2011.04.003" "Revista" => array:6 [ "tituloSerie" => "Sleep Med Rev" "fecha" => "2012" "volumen" => "16" "paginaInicial" => "151" "paginaFinal" => "166" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21641838" "web" => "Medline" ] ] ] ] ] ] ] ] 32 => array:3 [ "identificador" => "bib0430" "etiqueta" => "33" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Dipper and non-dipper blood pressure 24-hour patterns: circadian rhythm-dependent physiologic and pathophysiologic mechanisms" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "F. Fabbian" 1 => "M.H. Smolensky" 2 => "R. Tiseo" 3 => "M. Pala" 4 => "R. Manfredini" 5 => "F. Portaluppi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3109/07420528.2012.715872" "Revista" => array:6 [ "tituloSerie" => "Chronobiol Int" "fecha" => "2013" "volumen" => "30" "paginaInicial" => "17" "paginaFinal" => "30" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23002916" "web" => "Medline" ] ] ] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib0435" "etiqueta" => "34" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Computation of time-specified tolerance intervals for ambulatorily monitored blood pressure" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "R.C. Hermida" 1 => "J.R. Fernández" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Biomed Instrum Technol" "fecha" => "1996" "volumen" => "30" "paginaInicial" => "257" "paginaFinal" => "266" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8739002" "web" => "Medline" ] ] ] ] ] ] ] ] 34 => array:3 [ "identificador" => "bib0440" "etiqueta" => "35" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Circadian time-qualified tolerance intervals for ambulatory blood pressure monitoring in the diagnosis of hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "R.C. Hermida" 1 => "J.R. Fernández" 2 => "D.E. Ayala" 3 => "A. Mojón" 4 => "I. Alonso" 5 => "C. Calvo" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Chronobiol Int" "fecha" => "2004" "volumen" => "21" "paginaInicial" => "149" "paginaFinal" => "170" ] ] ] ] ] ] 35 => array:3 [ "identificador" => "bib0445" "etiqueta" => "36" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Computer-based medical system for the computation of blood pressure excess in the diagnosis of hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "R.C. Hermida" 1 => "A. Mojón" 2 => "J.R. Fernández" 3 => "D.E. Ayala" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Biomed Instrum Technol" "fecha" => "1996" "volumen" => "30" "paginaInicial" => "267" "paginaFinal" => "283" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8739003" "web" => "Medline" ] ] ] ] ] ] ] ] 36 => array:3 [ "identificador" => "bib0450" "etiqueta" => "37" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Reproducibility of the hyperbaric index as a measure of blood pressure excess" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "R.C. Hermida" 1 => "J.R. Fernández" 2 => "A. Mojón" 3 => "D.E. Ayala" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Hypertension" "fecha" => "2000" "volumen" => "35" "paginaInicial" => "118" "paginaFinal" => "125" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10642285" "web" => "Medline" ] ] ] ] ] ] ] ] 37 => array:3 [ "identificador" => "bib0455" "etiqueta" => "38" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The tolerance-hyperbaric test: a chronobiologic approach for improved diagnosis of hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "R.C. Hermida" 1 => "A. Mojón" 2 => "J.R. Fernández" 3 => "I. Alonso" 4 => "D.E. Ayala" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Chronobiol Int" "fecha" => "2002" "volumen" => "19" "paginaInicial" => "1183" "paginaFinal" => "1211" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12511034" "web" => "Medline" ] ] ] ] ] ] ] ] 38 => array:3 [ "identificador" => "bib0460" "etiqueta" => "39" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effects of the time of antihypertensive drugs administration on the stage of primary open-angle glaucoma in patients with arterial hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "B. Krasinska" 1 => "M. Karolczak-Kulesza" 2 => "Z. Krasinski" 3 => "K. Pawlaczyk-Gabriel" 4 => "P. Lopatka" 5 => "J. Gluszek" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3109/08037051.2012.666423" "Revista" => array:6 [ "tituloSerie" => "Blood Press" "fecha" => "2012" "volumen" => "21" "paginaInicial" => "240" "paginaFinal" => "248" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22424547" "web" => "Medline" ] ] ] ] ] ] ] ] 39 => array:3 [ "identificador" => "bib0465" "etiqueta" => "40" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Administration-time-dependent effect of blood pressure-lowering medications: basis for the chronotherapy of hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "M.H. Smolensky" 1 => "R.C. Hermida" 2 => "D.E. Ayala" 3 => "R. Tiseo" 4 => "F. Portaluppi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/MBP.0b013e32833c7308" "Revista" => array:6 [ "tituloSerie" => "Blood Press Monit" "fecha" => "2010" "volumen" => "15" "paginaInicial" => "173" "paginaFinal" => "180" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20571367" "web" => "Medline" ] ] ] ] ] ] ] ] 40 => array:3 [ "identificador" => "bib0470" "etiqueta" => "41" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Administration-time differences in effects of hypertension medications on ambulatory blood pressure regulation" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R.C. Hermida" 1 => "D.E. Ayala" 2 => "J.R. Fernández" 3 => "A. Mojón" 4 => "M.H. Smolensky" 5 => "F. Fabbian" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3109/07420528.2012.709448" "Revista" => array:6 [ "tituloSerie" => "Chronobiol Int" "fecha" => "2013" "volumen" => "30" "paginaInicial" => "280" "paginaFinal" => "314" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23077971" "web" => "Medline" ] ] ] ] ] ] ] ] 41 => array:3 [ "identificador" => "bib0475" "etiqueta" => "42" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cronoterapia con antihipertensivos para mejorar el control de la presión arterial y reducir el riesgo vascular" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "R.C. Hermida" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Med Clin (Barc)" "fecha" => "2015" "volumen" => "144" "paginaInicial" => "62" "paginaFinal" => "64" ] ] ] ] ] ] 42 => array:3 [ "identificador" => "bib0480" "etiqueta" => "43" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Circadian rhythms in blood pressure regulation and optimization of hypertension treatment with ACE inhibitor and ARB medications" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "R.C. Hermida" 1 => "D.E. Ayala" 2 => "J.R. Fernández" 3 => "F. Portaluppi" 4 => "F. Fabbian" 5 => "M.H. Smolensky" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/ajh.2010.217" "Revista" => array:6 [ "tituloSerie" => "Am J Hypertens" "fecha" => "2011" "volumen" => "24" "paginaInicial" => "383" "paginaFinal" => "391" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20930708" "web" => "Medline" ] ] ] ] ] ] ] ] 43 => array:3 [ "identificador" => "bib0485" "etiqueta" => "44" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "R.C. Hermida" 1 => "D.E. Ayala" 2 => "A. Mojón" 3 => "J.R. Fernández" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3109/07420528.2012.701534" "Revista" => array:6 [ "tituloSerie" => "Chronobiol Int" "fecha" => "2013" "volumen" => "30" "paginaInicial" => "315" "paginaFinal" => "327" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23181712" "web" => "Medline" ] ] ] ] ] ] ] ] 44 => array:3 [ "identificador" => "bib0490" "etiqueta" => "45" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evening dosing of antihypertensive therapy to reduce cardiovascular events: a third type of evidence based on a systematic review and meta-analysis of randomized trials" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "G.C. Roush" 1 => "J. Fapohunda" 2 => "J.B. Kostis" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Clin Hypertens (Greenwich)" "fecha" => "2014" "volumen" => "16" "paginaInicial" => "561" "paginaFinal" => "568" ] ] ] ] ] ] 45 => array:3 [ "identificador" => "bib0495" "etiqueta" => "46" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mortality in hypertensive patients with coronary heart disease depends on chronopharmacotherapy and dipping status" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "W. Sobiczewski" 1 => "M. Wirtwein" 2 => "M. Gruchala" 3 => "I. Kocic" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.pharep.2013.12.009" "Revista" => array:6 [ "tituloSerie" => "Pharmacol Rep" "fecha" => "2014" "volumen" => "66" "paginaInicial" => "448" "paginaFinal" => "452" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24905522" "web" => "Medline" ] ] ] ] ] ] ] ] 46 => array:3 [ "identificador" => "bib0500" "etiqueta" => "47" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D.E. Ayala" 1 => "A. Moyá" 2 => "J.J. Crespo" 3 => "C. Castiñeira" 4 => "M. Domínguez-Sardiña" 5 => "S. Gomara" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3109/07420528.2012.701489" "Revista" => array:6 [ "tituloSerie" => "Chronobiol Int" "fecha" => "2013" "volumen" => "30" "paginaInicial" => "99" "paginaFinal" => "115" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23098178" "web" => "Medline" ] ] ] ] ] ] ] ] 47 => array:3 [ "identificador" => "bib0505" "etiqueta" => "48" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Administration-time-dependent effects of hypertension treatment on ambulatory blood pressure in patients with chronic kidney disease" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.J. Crespo" 1 => "L. Piñeiro" 2 => "A. Otero" 3 => "C. Castiñeira" 4 => "M.T. Ríos" 5 => "A. Regueiro" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3109/07420528.2012.701459" "Revista" => array:6 [ "tituloSerie" => "Chronobiol Int" "fecha" => "2013" "volumen" => "30" "paginaInicial" => "159" "paginaFinal" => "175" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23098134" "web" => "Medline" ] ] ] ] ] ] ] ] 48 => array:3 [ "identificador" => "bib0510" "etiqueta" => "49" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effects of time-of-day of hypertension treatment on ambulatory blood pressure and clinical characteristics of patients with type 2 diabetes" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Moyá" 1 => "J.J. Crespo" 2 => "D.E. Ayala" 3 => "M.T. Ríos" 4 => "L. Pousa" 5 => "P.A. Callejas" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3109/07420528.2012.702587" "Revista" => array:6 [ "tituloSerie" => "Chronobiol Int" "fecha" => "2013" "volumen" => "30" "paginaInicial" => "116" "paginaFinal" => "131" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23181613" "web" => "Medline" ] ] ] ] ] ] ] ] 49 => array:3 [ "identificador" => "bib0515" "etiqueta" => "50" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Standards of medical care in diabetes – 2012" "autores" => array:1 [ 0 => array:2 [ "colaboracion" => "American Diabetes Association" "etal" => false ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2337/dc12-s011" "Revista" => array:7 [ "tituloSerie" => "Diabetes Care" "fecha" => "2012" "volumen" => "35" "numero" => "Suppl. 1" "paginaInicial" => "S11" "paginaFinal" => "S63" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22187469" "web" => "Medline" ] ] ] ] ] ] ] ] 50 => array:3 [ "identificador" => "bib0520" "etiqueta" => "51" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD)" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "L. Rydén" 1 => "P.J. Grant" 2 => "S.D. Anker" 3 => "C. Berne" 4 => "F. Cosentino" 5 => "N. Danchin" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/eurheartj/eht108" "Revista" => array:6 [ "tituloSerie" => "Eur Heart J" "fecha" => "2013" "volumen" => "34" "paginaInicial" => "3035" "paginaFinal" => "3087" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23996285" "web" => "Medline" ] ] ] ] ] ] ] ] 51 => array:3 [ "identificador" => "bib0525" "etiqueta" => "52" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2014)" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "K. Shimamoto" 1 => "K. Ando" 2 => "T. Fujita" 3 => "N. Hasebe" 4 => "J. Higaki" 5 => "M. Horiuchi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/hr.2014.20" "Revista" => array:6 [ "tituloSerie" => "Hypertens Res" "fecha" => "2014" "volumen" => "37" "paginaInicial" => "253" "paginaFinal" => "390" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24705419" "web" => "Medline" ] ] ] ] ] ] ] ] 52 => array:3 [ "identificador" => "bib0530" "etiqueta" => "53" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "2015 guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the management of hypertension" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C.E. Chiang" 1 => "T.D. Wang" 2 => "K.C. Ueng" 3 => "T.H. Lin" 4 => "H.I. Yeh" 5 => "C.Y. Chen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jcma.2014.11.005" "Revista" => array:6 [ "tituloSerie" => "J Chin Med Assoc" "fecha" => "2015" "volumen" => "78" "paginaInicial" => "1" "paginaFinal" => "47" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25547819" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/23870206/0000014600000001/v3_201605230108/S2387020616300687/v3_201605230108/en/main.assets" "Apartado" => array:4 [ "identificador" => "44145" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Special article" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/23870206/0000014600000001/v3_201605230108/S2387020616300687/v3_201605230108/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020616300687?idApp=UINPBA00004N" ]
Year/Month | Html | Total | |
---|---|---|---|
2016 December | 0 | 2 | 2 |